LTFS
EPIX

Ladenburg Thalmann Financial Services’s ESSA Pharma EPIX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
25
– – ﹤0.01% 5367
2019
Q3 		$0 Buy
+25
New +$62 ﹤0.01% 5320

Other funds holding EPIX

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ladenburg Thalmann Financial Services's EPIX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its ESSA Pharma (EPIX) position steady in Q4 2019 at 25 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5367.

Ladenburg Thalmann Financial Services first reported a position in EPIX in Q3 2019 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold EPIX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 25 shares of ESSA Pharma worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its ESSA Pharma share count unchanged in Q4 2019.
  • ESSA Pharma made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5367 holding.
  • Ladenburg Thalmann Financial Services first reported a position in ESSA Pharma in Q3 2019 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.